A Quenched Annexin V‐Fluorophore for the Real‐Time Fluorescence Imaging of Apoptotic Processes In Vitro and In Vivo
Source abstract
Abstract
Abstract Annexin‐based probes have long been used to study apoptotic cell death, which is of key importance to many areas of biological research, drug discovery, and clinical applications. Although apoptosis is a dynamic biological event with cell‐to‐cell variations, current annexin‐based probes are impractical for monitoring apoptosis in real‐time. Herein, a quenched annexin V‐near‐infrared fluorophore conjugate (Q‐annexin V) is reported as the first OFF‐ON annexin protein‐based molecular sensor for real‐time near‐infrared fluorescence imaging of apoptosis. Q‐annexin V is non‐fluorescent in the extracellular region, due to photoinduced electron transfer interactions between the conjugated dye and amino acid quenchers (tryptophan and tyrosine). The probe becomes highly fluorescent when bound to phosphatidylserines on the outer layer of cell membranes during apoptosis, thereby enabling apoptosis to be monitored in real‐time in 2D and 3D cell structures. In particular, Q‐annexin V shows superior utility for in vivo apoptosis fluorescence imaging in animal models of cisplatin‐induced acute kidney injury and cancer immune therapy, compared to the conventional polarity‐sensitive pSIVA‐IANBD or annexin V‐Alexa647 conjugates.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Nanoparticle-Based Drug Delivery · RNA Interference and Gene Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Research Institute National Cancer Center 323 Ilsan‐ro Goyang Gyeonggi 10408 Republic of Korea
Department of Cancer Biomedical Science National Cancer Center Graduate School of Cancer Science and Policy 323 Ilsan‐ro Goyang Gyeonggi 10408 Republic of Korea
Funding
National Cancer Center · Ministry of Oceans and Fisheries
References (39)
Show source-provided references
1. 10.1038/3503773410.1038/35037734 ↗
2. 10.1038/s41571-020-0341-y10.1038/s41571-020-0341-y ↗
3. 10.1038/s41586-019-0977-x10.1038/s41586-019-0977-x ↗
4. 10.1038/s41568-018-0007-610.1038/s41568-018-0007-6 ↗
5. 10.1038/nrc323910.1038/nrc3239 ↗
6. 10.1038/s41568-019-0186-910.1038/s41568-019-0186-9 ↗
7. 10.1016/j.ymeth.2007.11.01010.1016/j.ymeth.2007.11.010 ↗
8. 10.1038/nmeth.140510.1038/nmeth.1405 ↗
9. 10.1002/cphc.20050019110.1002/cphc.200500191 ↗
10. 10.1021/bc034132410.1021/bc0341324 ↗
11. 10.1021/bi100907m10.1021/bi100907m ↗
12. https://www.atto-tec.com/product_info.php?info=p115_atto-655.html(accessed: January2020).
13. 10.7150/thno.1664710.7150/thno.16647 ↗
14. 10.1016/S0014-5793(01)02285-210.1016/S0014-5793(01)02285-2 ↗
15. 10.1021/bi981289o10.1021/bi981289o ↗
16. 10.1021/bi982760g10.1021/bi982760g ↗
17. 10.1021/bi981967710.1021/bi9819677 ↗
18. 10.1006/bbrc.1997.659610.1006/bbrc.1997.6596 ↗
19. 10.1021/jp404466f10.1021/jp404466f ↗
20. 10.1021/acs.jpclett.7b0243010.1021/acs.jpclett.7b02430 ↗
21. 10.1007/s00249-015-1068-z10.1007/s00249-015-1068-z ↗
22. 10.1002/stem.207310.1002/stem.2073 ↗
23. 10.1038/7419910.1038/74199 ↗
24. 10.1016/j.stem.2012.03.00110.1016/j.stem.2012.03.001 ↗
25. 10.1083/jcb.20020307310.1083/jcb.200203073 ↗
26. 10.1007/s40620-017-0392-z10.1007/s40620-017-0392-z ↗
27. 10.1039/C8DT00838H10.1039/C8DT00838H ↗
28. 10.3390/ijms2012301110.3390/ijms20123011 ↗
29. Avci P. · Semin. Cutaneous Med. Surg. · 2013 · 32 · 41
30. 10.1158/2326-6066.CIR-14-011810.1158/2326-6066.CIR-14-0118 ↗
31. 10.1038/nbt.246810.1038/nbt.2468 ↗
32. 10.1038/s41588-018-0209-610.1038/s41588-018-0209-6 ↗
33. 10.1038/nm0103-12310.1038/nm0103-123 ↗
34. 10.1016/j.ejso.2009.10.01410.1016/j.ejso.2009.10.014 ↗
35. Tait J. F. · J. Nucl. Med. · 2005 · 46 · 807
36. 10.1038/nbt134010.1038/nbt1340 ↗
37. 10.1016/j.bbrc.2018.07.14510.1016/j.bbrc.2018.07.145 ↗
38. 10.1038/nsmb.165710.1038/nsmb.1657 ↗
39. Kim H. Y. · Exp. Mol. Med. · 2018 · 50 · 137